TAK Q1 2026 Earnings NarrowerthanExpected Loss as EPS Surprises Positively ISPC Q3 2024 Earnings Significant EPS Miss Amid Operational Challenges DBGI Q3 2023 Earnings Significant Loss Per Share Amid Stock Decline Serina Therapeutics Inc SER Q1 2026 Earnings EPS Miss Amid Continued Development Progress EXC Q1 2026 Earnings Slight EPS Beat Bolsters Utilitys Steady Outlook MTRX Q1 2026 Earnings Strong EPS Beat Drives Investor Optimism IMMX Q1 2026 Earnings Smallerthanexpected loss drives positive sentiment Quantum Biopharma Ltd QNTM Q4 2025 Earnings Narrowing Losses Amidst No Revenue Disclosure Fulcrum Therapeutics FULC Q1 2026 Earnings NarrowerthanExpected Loss Despite Mild Stock Dip DFLI Q1 2026 Earnings EPS Misses Estimates Despite Stock Gain UFCS Q1 2026 Earnings Strong EPS Beat Reflects Improved Underwriting Performance ADIL Q1 2026 Earnings Narrowing Loss Beats Estimates But Stock Declines Amid No Revenue